Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells

Journal of the National Cancer Institute

Volumn 92, Issue 4, 2000, Pages 338-344

  Wu, Rong ^a   Connolly, Denise C ^a   Dunn, Rodney L ^b   Cho, Kathleen R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER INVASION; CARCINOMA CELL; CHROMOSOME 3P; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

EID: 0034673252     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.4.338     Document Type: Article

References (30)

1. Alani RM, Munger K, Human papillomaviruses and associated malignancies. J Clin Oncol 1998;16:330-7.
2. Chu TY, Shen CY, Chiou YS, Lu JJ, Perng CL, Yu MS, et al. HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHlT mRNA. Int J Cancer 1998;75:199-204.
3. Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, et al. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 1993; 8:1825-32.
4. Larson AA, Kem S, Curtiss S, Gordon R, Cavenee WK, Hampton GM, High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res 1997;57:4082-90.
5. Wistuba II, Montellano FD, Milchgrub S. Virmani AK, Behrens C, Chen H, et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 1997;57:3154-8.
6. Rader JS, Gerhard DS, O'Sullivan MJ, Li Y, Li L, Liapis H, et al. Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. Genes Chromosomes Cancer 1998;22:57-65.
7. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54:4481-7.
8. Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989;49:3598-601.
9. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
10. 3-triphosphate hydrolase. Biochemistry 1996;35:11529-35.
11. Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, McKeithan TW, et al. An FHIT tumor suppressor gene? Genes Chromosomes Cancer 1998;21:281-9.
12. Druck T, Berk L, Huebner K. FHITness and cancer. Oncol Res 1998;10:341-5.
13. Mao L. Tumor suppressor genes: does FHIT fit? J Natl Cancer Inst 1998;90:412-4.
14. Huebner K, Garrison PN, Barnes LD, Croce CM. The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 1998;32:7-31.
15. Sard L, Accornero P, Tornielli S, Delia D, Bunone G. Campiglio M, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci U S A 1999;96:8489-92.
16. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res 1999; 59:3333-9.
17. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, et al. Replacement of FHIT in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1998;94: 13771-6.
18. Otterson GA, Xiao GH. Geradts J, Jin F, Chen WD, Niklinska W, et al. Protein expression and functional analysis of the FHIT gene in human tumor cells. J Natl Cancer Inst 1998;90: 426-32.
19. Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, et al. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 1997;57:4692-8.
20. Muller CY, O'Boyle JD, Fong KM, Wistuba II, Biesterveld E, Ahmadian M, et al. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst 1998;90:433-9.
21. Yoshino K, Enomoto T, Nakamura T, Nakashima R, Wada H, Saitoh J, et al. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 1998;76: 176-81.
22. Nakagawa S, Yoshikawa H, Kimura M, Kawana K, Matsumoto K, Onda T, et al. A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. Br J Cancer 1999;79:589-94.
23. Birrer MJ, Hendricks D, Farley J, Sundborg MJ, Bonome T, Walts MJ, et al. Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res 1999; 59:5270-4.
24. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site; direct evidence for the coincidence of viral integration sites and fragile sites. Hum Genet 1996; 5:187-95.
25. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A 1993;90:3988-92.
26. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996;7:1405-13.
27. Druck T, Hadacrek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997;57:504-12.
28. Boldog FL, Gemmill RM, West J, Robinson M, Robinson L, Li E, et al. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 1997;6:193-203.
29. Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, et al. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res 1997;57:5207-12.
30. Virgilio L, Shuster M, Gollin SM. Veronese ML, Ohta M, Huebner K, et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 1996;93: 9770-5.